Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1996 Sep;74(5):766–772. doi: 10.1038/bjc.1996.434

Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.

L P Setälä 1, V M Kosma 1, S Marin 1, P K Lipponen 1, M J Eskelinen 1, K J Syrjänen 1, E M Alhava 1
PMCID: PMC2074696  PMID: 8795580

Abstract

A retrospective analysis of 321 gastric cancer patients was made to assess the prognostic value of TNM classification, tumour differentiation, Laurén classification, proliferative rate, inflammatory reaction and tumour invasion in vascular or neural structures of the gastric wall. The TNM classification showed the strongest correlation with survival in univariate and multivariate analyses (P < 0.0001). The invasion in lymphatic or vascular system and Laurén classification were also independent prognosticators in multivariate analysis (P < 0.05). In univariate analysis, the WHO-grade, the size and the location of the tumour and perinueral invasion were significant prognostic factors (P < 0.01), as were the infiltration of lymphocytes and plasma cells in the tumour (P < 0.05). On the other hand, the mitotic indices reflecting the proliferative activity of the tumour cells showed no significant correlation with the prognosis. The results indicate that the prognostic power of the TNM classification can be further increased by assessment of the above special histological features in gastric cancer.

Full text

PDF
766

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltomaa S., Lipponen P., Eskelinen M., Kosma V. M., Marin S., Alhava E., Syrjänen K. Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol. 1992;118(1):75–81. doi: 10.1007/BF01192316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonenkamp J. J., Songun I., Hermans J., Sasako M., Welvaart K., Plukker J. T., van Elk P., Obertop H., Gouma D. J., Taat C. W. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995 Mar 25;345(8952):745–748. doi: 10.1016/s0140-6736(95)90637-1. [DOI] [PubMed] [Google Scholar]
  3. Concetti H. F., Kato Y., Sugano H., Kitagawa T. Natural history of gastric carcinoma with special reference to the "early cancer" stage: a mitotic index study on original and recurrent carcinomas. Gan. 1981 Oct;72(5):665–672. [PubMed] [Google Scholar]
  4. Cross S. S., Start R. D., Smith J. H. Does delay in fixation affect the number of mitotic figures in processed tissue? J Clin Pathol. 1990 Jul;43(7):597–599. doi: 10.1136/jcp.43.7.597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Davessar K., Pezzullo J. C., Kessimian N., Hale J. H., Jauregui H. O. Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol. 1990 Mar;21(3):325–332. doi: 10.1016/0046-8177(90)90234-v. [DOI] [PubMed] [Google Scholar]
  6. Gabbert H. E., Meier S., Gerharz C. D., Hommel G. Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer. 1991 Sep 9;49(2):203–207. doi: 10.1002/ijc.2910490210. [DOI] [PubMed] [Google Scholar]
  7. Haapasalo H., Pesonen E., Collan Y. Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms. Pathol Res Pract. 1989 Nov;185(5):551–554. doi: 10.1016/S0344-0338(89)80191-8. [DOI] [PubMed] [Google Scholar]
  8. Haugstvedt T. K., Viste A., Eide G. E., Söreide O. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg. 1993 Apr;80(4):475–478. doi: 10.1002/bjs.1800800423. [DOI] [PubMed] [Google Scholar]
  9. Hermanek P. Prognostic factors in stomach cancer surgery. Eur J Surg Oncol. 1986 Sep;12(3):241–246. [PubMed] [Google Scholar]
  10. Hermanek P., Wittekind C. News of TNM and its use for classification of gastric cancer. World J Surg. 1995 Jul-Aug;19(4):491–495. doi: 10.1007/BF00294707. [DOI] [PubMed] [Google Scholar]
  11. Hermans J., Bonenkamp J. J., Boon M. C., Bunt A. M., Ohyama S., Sasako M., Van de Velde C. J. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol. 1993 Aug;11(8):1441–1447. doi: 10.1200/JCO.1993.11.8.1441. [DOI] [PubMed] [Google Scholar]
  12. Iriyama K., Miki C., Ilunga K., Osawa T., Tsuchibashi T., Suzuki H. Prognostic significance of histological type in gastric carcinoma with invasion confined to the stomach wall. Br J Surg. 1993 Jul;80(7):890–892. doi: 10.1002/bjs.1800800729. [DOI] [PubMed] [Google Scholar]
  13. Korenaga D., Ikeda T., Maehara Y., Sugimachi K. [Cytophotometrically determined DNA content, mitotic index and proliferative activity clinical gastric cancer]. Gan To Kagaku Ryoho. 1995 Jun;22 (Suppl 2):168–171. [PubMed] [Google Scholar]
  14. Korenaga D., Saito A., Baba H., Watanabe A., Okamura T., Maehara Y., Sugimachi K. Cytophotometrically determined DNA content, mitotic activity, and lymph node metastasis in clinical gastric cancer. Surgery. 1990 Mar;107(3):262–267. [PubMed] [Google Scholar]
  15. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  16. Lipponen P. K., Eskelinen M. J., Jauhiainen K., Harju E., Terho R. Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer. 1992;29A(1):69–75. doi: 10.1016/0959-8049(93)90579-5. [DOI] [PubMed] [Google Scholar]
  17. Lipponen P. K., Kosma V. M., Collan Y., Kulju T., Kosunen O., Eskelinen M. Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. Eur Urol. 1990;17(4):333–337. doi: 10.1159/000464075. [DOI] [PubMed] [Google Scholar]
  18. Lisborg P., Jatzko G., Horn M., Neumann H. J., Müller M., Stettner H., Denk H. Radical surgery (R2 resection) for gastric cancer. A multivariate analysis. Scand J Gastroenterol. 1994 Nov;29(11):1024–1028. doi: 10.3109/00365529409094880. [DOI] [PubMed] [Google Scholar]
  19. Mori M., Adachi Y., Kamakura T., Ikeda Y., Maehara Y., Sugimachi K. Neural invasion in gastric carcinoma. J Clin Pathol. 1995 Feb;48(2):137–142. doi: 10.1136/jcp.48.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Noguchi Y. Blood vessel invasion in gastric carcinoma. Surgery. 1990 Feb;107(2):140–148. [PubMed] [Google Scholar]
  21. Noguchi Y., Imada T., Matsumoto A., Coit D. G., Brennan M. F. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer. 1989 Nov 15;64(10):2053–2062. doi: 10.1002/1097-0142(19891115)64:10<2053::aid-cncr2820641014>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  22. Okada M., Kojima S., Murakami M., Fuchigami T., Yao T., Omae T., Iwashita A. Human gastric carcinoma: prognosis in relation to macroscopic and microscopic features of the primary tumor. J Natl Cancer Inst. 1983 Aug;71(2):275–279. [PubMed] [Google Scholar]
  23. Schmitz-Moormann P., Hermanek P., Himmelmann G. W. Morphological predictors of survival in early and advanced gastric carcinoma. J Cancer Res Clin Oncol. 1992;118(4):296–302. doi: 10.1007/BF01208619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Siewert J. R., Böttcher K., Roder J. D., Busch R., Hermanek P., Meyer H. J. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg. 1993 Aug;80(8):1015–1018. doi: 10.1002/bjs.1800800829. [DOI] [PubMed] [Google Scholar]
  25. Tabuchi Y., Takiguchi Y., Nakamura T., Nakae S., Imanishi K., Murayama Y., Saitoh Y. [Mitotic activity of cancer cells and survival of gastric cancer patients]. Nihon Geka Gakkai Zasshi. 1986 Jan;87(1):44–48. [PubMed] [Google Scholar]
  26. Tanaka A., Watanabe T., Okuno K., Yasutomi M. Perineural invasion as a predictor of recurrence of gastric cancer. Cancer. 1994 Feb 1;73(3):550–555. doi: 10.1002/1097-0142(19940201)73:3<550::aid-cncr2820730309>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  27. Vesalainen S., Lipponen P., Talja M., Syrjänen K. Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate. 1995 Feb;26(2):80–86. doi: 10.1002/pros.2990260204. [DOI] [PubMed] [Google Scholar]
  28. Yu C. C., Levison D. A., Dunn J. A., Ward L. C., Demonakou M., Allum W. H., Hallisey M. T. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer. 1995 May;71(5):1106–1110. doi: 10.1038/bjc.1995.214. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES